200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 2215-21-6
CAS No: 2215-21-6 Catalog No: AG003INN MDL No:MFCD00008884
Title | Journal |
---|---|
Copper(II) complexes of salicylic acid combining superoxide dismutase mimetic properties with DNA binding and cleaving capabilities display promising chemotherapeutic potential with fast acting in vitro cytotoxicity against cisplatin sensitive and resistant cancer cell lines. | Journal of medicinal chemistry 20120308 |
Irbesartan inhibits advanced glycation end product (AGE)-induced up-regulation of vascular cell adhesion molecule-1 (VCAM-1) mRNA levels in glomerular endothelial cells. | Microvascular research 20110501 |
Fabrication and mechanical properties of PLLA/PCL/HA composites via a biomimetic, dip coating, and hot compression procedure. | Journal of materials science. Materials in medicine 20100601 |
Fluorescence labelling of DNA by carboxylic polypyridyl-Ru complexes containing bpy and DIP ligands: a study revisited. | Journal of fluorescence 20100501 |
Bis(2,2'-bipyridyl-κN,N')bis-(2-hydroxy-benzoato)-κO;κO,O-cadmium(II) methanol solvate. | Acta crystallographica. Section E, Structure reports online 20100201 |
Deoxyribonuclease I is essential for DNA fragmentation induced by gamma radiation in mice. | Radiation research 20091001 |
Synthesis and anticancer activity of lipophilic platinum(II) complexes of 3,5-diisopropylsalicylate. | European journal of medicinal chemistry 20080701 |
Copper(II) interaction with 3,5-diisopropylsalicylic acid (Dips): new insights on its role as a potential *OH inactivating ligand. | Journal of inorganic biochemistry 20070401 |
Redox-dependent effects of nitric oxide on microvascular integrity in oxygen-induced retinopathy. | Free radical biology & medicine 20041201 |
Pharmacokinetic distribution of 67Cu(II)2[3,5-diisopropyl(carboxy-14C)salicylate]4 among murine tissues. | Current medicinal chemistry 20041101 |
Pharmacological and haematological results of rat skin burn injury treatment with Cu(II)2(3,5-diisopropylsalicylate)4. | Inflammopharmacology 20040101 |
Ultraviolet-B-induced oxidative DNA base damage in primary normal human epidermal keratinocytes and inhibition by a hydroxyl radical scavenger. | The Journal of investigative dermatology 20030701 |
Activation of calcium-dependent calmodulin by calcium(II)3(3,5-diisopropylsalicylate)6(H2O)6 decreases thrombin receptor activating peptide-induced P-selectin expression. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20030201 |
Protection against cisplatin-induced nephrotoxicity by Cu(II)2(3,5-diisopropylsalicylate)4. | Redox report : communications in free radical research 20030101 |
Interleukin 17, a nitric oxide-producing cytokine with a peroxynitrite-independent inhibitory effect on proteoglycan synthesis. | The Journal of rheumatology 20021201 |
[Crystallochemistry of copper (II) and zinc (II) chelates by nonsteroidal antiinflammatory drugs]. | Annales pharmaceutiques francaises 20020301 |
Nitric oxide (NO) and cartilage metabolism: NO effects are modulated by superoxide in response to IL-1. | Biorheology 20020101 |
© 2019 Angene International Limited. All rights Reserved.